Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 062877/0275 | |
| Pages: | 5 |
| | Recorded: | 03/03/2023 | | |
Attorney Dkt #: | 2023-0359A |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18024641
|
Filing Dt:
|
03/03/2023
|
Publication #:
|
|
Pub Dt:
|
10/12/2023
| | | | |
Title:
|
ANTIVIRAL SILENCING RNA MOLECULES, CHEMICALLY MODIFIED ANTIVIRAL SILENCING RNA MOLECULES WITH ENHANCED CELL PENETRATING ABILITIES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF FOR TREATMENT OF VIRAL INFECTIONS
|
|
Assignee
|
|
|
330-1595 BOUL. DANIEL JOHNSON |
LAVAL, QC, CANADA H7V 4C2 |
|
Correspondence name and address
|
|
WENDEROTH, LIND & PONACK, L.L.P.
|
|
1025 CONNECTICUT AVENUE NW
|
|
SUITE 500
|
|
WASHINGTON, DC 20036
|
Search Results as of:
05/07/2024 09:14 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|